Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3607)	4/27/2001 9:01:10 AM
From: Biomaven	of 52153

Bernard, I think by far the dominant IPIC driver is pagoclone. I succumbed to temptation and bought a little late last year and it's done far better than the "respectable" companies I own. Incidentally IPIC was the first biotech I ever bought. That's where I learnt about isomers (dexfenfluramine) which then eventually lead me to SEPR. Fortunately I had gotten out before the fenfluramine heart-damage debacle and my IPIC profits lead me down the slippery slope of biotechnutdom. IPIC was pure beginners luck. My next set of investments were the instant-test companies (like QDEL) and also Matritech (seemed a good story at the time). Those didn't pan out too well, but by then I was too far gone to retreat to the comparative sanity of high-tech. <g> Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next